jeudi 9 mars 2017

Onco Actu du 9 mars 2017

3. Prévention

Experts call for increased efforts to prevent cancer [WUSTL]

3.1 Tabac

Smoking rates in the UK hit record low [Cancer Research UK]

4. Dépistage, diagnostic et pronostic

Testing for Hepatitis C Virus Remains Low among Baby Boomers [ACS]

Few Boomers Get Hepatitis C Test Even Though It Can Save Lives [Dr. Len]

4.5 Dép., diag. & prono. - Colorectal

I learned the hard way that colon cancer is on the rise among younger people [STAT]

5. Traitements

Mayo Clinic researchers identify therapy that shrinks tumors in patients with multiple myeloma [Mayo Clinic]

5.10 Traitements - Essais

Trial Type and Time to Enrolling First Patient Linked to Slow Patient Accrual in Cancer Clinical Trials [AACR]

Cancer treatments 'not being trialled in children' [BBC News]

5.12.2 Immunothérapies - CAR-T

Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia [Cellectis]

5.2 Pharma

Langer-backed cancer, fibrotic upstart XTuit takes on ex-Forum chief as CEO [FierceBiotech]

Bristol-Myers Squibb Appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer [BMS]

Under the gun after Opdivo setbacks, Bristol-Myers Squibb names a new chief scientist [EndPoints]

5.4 Traitements - Economie

Do big R&D budgets justify US premium drug prices? No way, analysts scoff [EndPoints]

6.10 Politiques

Show drugs work before selling them [Nature]

UK children with cancer could miss out on drug trials after Brexit, doctors warn [The Guardian]

6.10.1 Politiques (USA)

ASCO Raises Concerns about ACA Market Stabilization Proposal [ASCO]

Statement from ASH President on Introduction of the Cancer Drug Parity Act [ASH]

6.5 Médecines alternatives

Hallelujah! The mainstream press finally notices quackademic medicine! [Respectful Insolence]

6.7 DMP, Big Data & applis

Medical Community Urges Delay in Requiring 2015 CEHRT [ASCO]

Leading Oncology Professional Societies Launch CancerLinQ® Ambassadors Program [ASCO]

6.9 Controverses

DePinho Announces His Departure from Houston’s MD Anderson [Xconomy]

Ronald DePinho, embattled chief of MD Anderson Cancer Center, resigns [STAT]

Cancer researcher has dodged accusations for decades (and has a new correction) [Retraction Watch]

Years of Ethics Charges, but Star Cancer Researcher Gets a Pass [NY Times]